SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

To perform biospecimen and data based high quality research aiming to better understand the biology of cancer, and/or how it is currently managed and/or how to better diagnose and treat it in the future;

Time frame: 5 years

To investigate the molecular pathways related to the development of specific tumors from a biological point of view;

Time frame: 5 years

To investigate the effect of cancer treatment on the tumor, microenvironment and patients globally;

Time frame: 5 years

To collect large series of homogeneous clinical data to analyse the disease course and treatment performed;

Time frame: 5 years

To investigate the prevalence and validate the prognostic or predictive value of novel biomarkers in cancers;

Time frame: 5 years

To perform biospecimen and data based high quality research aiming to facilitate the discovery of new test for tumor biomarkers or facilitate the establishment of validated tests for tumor biomarkers;

Time frame: 5 years

To identify patients with molecular alterations in their tumor that can be matched to biomarker-driven clinical trials, to facilitate enrollment of cancer patients in biomarker-driven clinical trials.